CHU Pellegrin
CHU Pellegrin
Bordeaux, France2 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Post-market Clinical Follow-up Study of NEMOST V2 | Consent Forms; Scoliosis Idiopathic; Scoliosis Neuromuscular | Recruiting | Not applicable | 2026-02-11 | NCT07403084 | |
| Acute Myeloid Leukemia At Initial Diagnosis and/or Relapse in Children, Teenagers and Young Adults: Molecular Profiling, Multidrug Testing and MSC Interaction Studies | Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia, disease susceptibility, hematologic disorder, inherited disease susceptibility, leukemia, myeloid leukemia, neoplasm | Recruiting | Not stated | 2024-06-26 | NCT05772559 |